Tempest Therapeutics, Inc. (TPST) Insider Trading
0 insider purchases in the last 7 days
No open market insider purchases at Tempest Therapeutics, Inc. in the last 7 days.
Want more?
Sign up free to see 30+ days of history, set alerts, and track TPST on your watchlist.
Start for FreeAbout Tempest Therapeutics, Inc. Insider Trading
1 insider at Tempest Therapeutics, Inc. (TPST) has purchased stock in the past 90 days, totaling $500K across 1 transaction (231,482 shares).
The most recent purchase was by CEO Angel Matthew on March 24, 2026 — a $500K buy of 231,482 shares at $2.16, bringing their total holdings to 231,482 shares.
Track TPST insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.